financetom
Business
financetom
/
Business
/
IBM Partners With Amazon-Backed Anthropic to Integrate Claude Into Software Portfolio
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
IBM Partners With Amazon-Backed Anthropic to Integrate Claude Into Software Portfolio
Oct 7, 2025 3:53 AM

06:45 AM EDT, 10/07/2025 (MT Newswires) -- International Business Machines ( IBM ) and Anthropic, in which Amazon ( AMZN ) holds a stake, will form a partnership to integrate the Claude family of large language models into the technology company's software portfolio, the companies said on Tuesday.

The companies said Claude will first be integrated into IBM's ( IBM ) new artificial intelligence-first integrated development environment, or IDE, the companies said.

IBM ( IBM ) is exploring plans to include Claude in additional products in the future, the parties said.

The companies said they will collaborate to develop a guide for designing and managing enterprise AI agents.

Financial terms of the partnership were not disclosed.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vertex Swings to Q2 Net Income, Revenue Rises
Vertex Swings to Q2 Net Income, Revenue Rises
Aug 4, 2025
04:23 PM EDT, 08/04/2025 (MT Newswires) -- Vertex Pharmaceuticals ( VRTX ) reported fiscal Q2 non-GAAP net income late Monday of $4.52 per diluted share, swinging from a loss of $12.83 a year earlier. Analysts polled by FactSet expected earnings of $4.27. Revenue in the three months ended June 30 rose to $2.96 billion from $2.65 billion a year earlier....
BioMarin Pharma Q2 revenue beats estimates
BioMarin Pharma Q2 revenue beats estimates
Aug 4, 2025
Overview * BioMarin Q2 2025 revenue rises 16% yr/yr, beating analyst expectations * Non-GAAP diluted EPS for Q2 beats estimates, rising 50% yr/yr * Co completes acquisition of Inozyme, adding BMN 401 to enzyme therapies Outlook * BioMarin raises full-year 2025 revenue guidance to $3.125 bln-$3.200 bln * Company expects 2025 Non-GAAP EPS of $4.40 to $4.55 * BioMarin sees...
Syndax Pharmaceuticals Q2 net loss widens
Syndax Pharmaceuticals Q2 net loss widens
Aug 4, 2025
Overview * net lossof $71.8 mln, or $0.83 per share, versus loss of $68.1 million, or $0.80 per share year ago * Syndax Q2 Revuforj rev grows 43% compared with first quarter * Niktimvo shows significant growth in first full quarter of U.S. launch * Co holds $517.9 mln in cash, supporting path to profitability Outlook * Syndax expects stable...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved